Tech Company Financing Transactions
Lakewood-Amedex Funding Round
Lakewood-Amedex secured a $5.5 million Series C funding round on 6/19/2014. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/19/2014
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series C
Investors
Proceeds Purpose
The company will use the funds to advance is novel broad-spectrum Bisphosphocin class of antimicrobials into human clinical trials, increase its business development activities including seeking collaborations and partnerships to advance its orally available 'gene silencing' nRNA therapeutics for the treatment of various viral indications, oncology applications, inflammatory conditions and other chronic human diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3030 University Pkwy.
Sarasota, FL 34243
USA
Sarasota, FL 34243
USA
Phone
Website
Email Address
Overview
Lakewood-Amedex is developing therapeutics capable of binding deadly toxins produced by bacteria that cause severe illness and often fatalities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Parkinson
Chief Medical Officer
Patrick O'Connor
Controller
Peter Ceccacci
Browse more venture capital transactions:
Prev: 6/19/2014: Seventh Sense Biosystems venture capital transaction
Next: 6/19/2014: LogFire venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs